Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome - Poll - MDSpire

Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome

  • By

  • Nour Eldeen Mahmoud Shabaan Ibrahim

  • Mohamed Tarek Mounir Zaki

  • Khaled Ahmed Fouad Abdel Magid

  • Khaled Ahmed Fouad

  • Mina Magued Abdalla Iskandar

  • March 27, 2026

  • 0 min

Share

Original Source(s)

Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome

  • by Nour Eldeen Mahmoud Shabaan Ibrahim, Mohamed Tarek Mounir Zaki, Khaled Ahmed Fouad Abdel Magid, Khaled Ahmed Fouad, Mina Magued Abdalla Iskandar

  • March 27, 2026

Related Content

Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.

Association between hemoglobin glycation index and all-cause mortality in patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention